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Abstract
Pathogen-pattern-recognition by Toll-like receptors (TLRs) and pathogen clearance after immune complex formation via
engagement with Fc receptors (FcRs) represent central mechanisms that trigger the immune and inflammatory responses.
In the present study, a linkage between TLR4 and FccR was evaluated in vitro and in vivo. Most strikingly, in vitro activation
of phagocytes by IgG immune complexes (IgGIC) resulted in an association of TLR4 with FccRIII (CD16) based on co-
immunoprecipitation analyses. Neutrophils and macrophages from TLR4 mutant (mut) mice were unresponsive to either
lipopolysaccharide (LPS) or IgGIC in vitro, as determined by cytokine production. This phenomenon was accompanied by
the inability to phosphorylate tyrosine residues within immunoreceptor tyrosine-based activation motifs (ITAMs) of the
FcRc-subunit. To transfer these findings in vivo, two different models of acute lung injury (ALI) induced by intratracheal
administration of either LPS or IgGIC were employed. As expected, LPS-induced ALI was abolished in TLR4 mut and TLR4
2/2
mice. Unexpectedly, TLR4 mut and TLR4
2/2 mice were also resistant to development of ALI following IgGIC deposition in
the lungs. In conclusion, our findings suggest that TLR4 and FccRIII pathways are structurally and functionally connected at
the receptor level and that TLR4 is indispensable for FccRIII signaling via FcRc-subunit activation.
Citation: Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, et al. (2009) Cross-Talk between TLR4 and FccReceptorIII (CD16) Pathways. PLoS Pathog 5(6):
e1000464. doi:10.1371/journal.ppat.1000464
Editor: Danny C. Douek, NIH/NIAID, United States of America
Received October 31, 2008; Accepted May 4, 2009; Published June 5, 2009
Copyright:  2009 Rittirsch et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants GM-29507, GM-61656 (www.nigms.nih.gov) and HL-31963 (www.nhlbi.nih.gov) to
PAW, and German Research Foundation grant HU 823/2-2 (www.dfg.de) to MSH-L. The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pward@umich.edu
Introduction
The immune system is traditionally divided into innate and
adaptive entities. Adaptive immunity is organized around T cells
and B cells and requires a process of maturation and clonal
selection of lymphocytes. In contrast, innate immunity can be
immediately activated during the onset of infection in order to
control replication of pathogenic microbes and bring about their
clearance from tissues or blood. As an important aspect of innate
immunity, pattern-recognition receptors (PRRs) collectively rec-
ognize lipid, carbohydrate, peptide, and nucleic-acid structures of
invading microorganisms [1]. PRRs comprise the toll-like receptor
family (TLR), which consists of at least 12 different evolutionarily
conserved membrane proteins that trigger innate immune
responses [2]. Initially identified in 1997, TLR4 represents the
most thoroughly investigated TLR [3]. TLR4 is essential for
responses to bacterial lipopolysaccharide (LPS), a well-known
pathogen-associated molecular pattern (PAMP) [3,4]. Besides
LPS, various endogenous ligands, such as hyaluronan and high
mobility group box 1 protein (HMGB1), appear to engage TLR4
[5,6]. After binding of LPS to the TLR4/MD-2/CD14 receptor
complex, activation of the intracellular signaling pathway is
initiated, ultimately leading to NF-kB activation and its translo-
cation to the nucleus, resulting in subsequent cytokine/chemokine
production and release [7].
As part of the adaptive immune system,antibodies of highaffinity
binding specifically recognize and neutralize intruding pathogens or
their products. After antibody binding to antigen, the Fc domain of
immunoglobulin (Ig) is recognized by Fc receptors (FcRs) which are
predominantly expressed on immune and inflammatory cells and
thereby link antibody-mediated (humoral) immune responses to
cellular effector functions [8,9]. Specific FcRs exist for all classes of
immunoglobulins. Binding of IgGs to FccRs on phagocytes triggers
a wide variety of cellular functions including phagocytosis, release of
inflammatory mediators, and clearance of immune complexes [8].
FccRs specifically bind IgG and are divided into four subclasses.
FccRI (CD64), FccRIII (CD16), and FccRIV are activating
receptors, while FccRII (CD32) mediates inhibitory functions.
The cellular response is determined by the balance between
activating (ITAM, immunoreceptor tyrosine-based activation motif)
and inhibitory (ITIM, immunoreceptor tyrosine-based inhibitory
motif) signals [10,11,12,13].
Despite extensive research in the past, the highly complex
regulation of innate and adaptive immunity and their interactions
are still poorly understood. It has been suggested that adaptive
immune responses are controlled by innate immune recognition
and vice versa [14,15,16]. In particular, TLRs and FccRs are
considered to be important regulators of immune responses
[13,17]. Recently, evidence has emerged that there is indirect
interaction between TLR4 and FccR pathways. TLR4 has been
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complex arthritis; inhibition of TLR4 resulted in attenuation of in
vivo cytokine release in models of glomerulonephritis and
rheumatoid arthritis [18,19,20]. In the present study, we addressed
the question as to whether there is a direct link between TLR4 and
FccR pathways in vitro and in vivo.
Results
Exclusion of LPS Contamination of Reagents
In the past, the investigation of TLR4 faced the problem of LPS
contamination, which imposed considerable restrictions on the
interpretation of data [5]. Therefore, the LPS concentration was
determined in reagents used for lung injury induction by
deposition of IgG immune complexes (IgGIC), such as DPBS,
anti-BSA IgG and BSA, although none of these reagents had been
prepared using bacterial (E.coli) systems. Using Limulus Amebo-
cyte Lysate Kinetic-QCL assay, LPS levels were not detectable
(,5610
23 units/ml) in any of the reagents (data not shown),
suggesting that in vitro stimulation by IgGIC is based upon a
genuine agonist effect that is not due to LPS contamination. In
addition to determination of LPS contamination (see above),
DPBS, anti-BSA IgG and BSA were subjected to endotoxin
removal by solid-phase polymyxin. Using the polymyxin-treated
reagents, immune complexes were generated and then applied in
in vitro experiments or the reagents were administered in mice for
the formation of immune complexes in vivo. Furthermore,
commercially available, preformed peroxidase/anti-peroxidase
immune complexes (PAP IgGIC) were used at the same
concentration in order to confirm the results using BSA IgGIC
or polymyxin-treated BSA IgGIC. The results of both, polymyxin-
treated BSA IgGIC and PAP IgGIC, are presented in the
corresponding figures. In summary, using different in vitro and in
vivo approaches, it is highly unlikely that any of the effects following
IgGIC stimulation in the present study are based on LPS
contamination of the reagents.
Association between TLR4 and FccRIII after IgG Immune
Complex Activation
In order to assess whether crosstalk between TLR4 and FccR
might occur at the receptor level, neutrophils (PMNs) and
macrophages from wild-type (Wt) mice were incubated in vitro
with IgGIC, LPS, or the combination of the two. After incubation,
cell lysates were immunoprecipitated (IP) with anti-TLR4 and
then analyzed for FccRII/III by immunoblotting (IB). As shown in
Figure 1A,B, immunoprecipitated TLR4 was associated with
FccR after cell exposure to IgGIC. Inversely, LPS incubation did
not result in an association of both receptors as indicated by the
absence of bands for FccR, whereas the combination of
LPS+IgGIC seemed to enhance the signal for FccR co-
immunoprecipitated by anti-TLR4 IgG (Figure 1A,B). The band
for FccR under the conditions described above indicated a protein
mass of 55 kDa, in accord with the reported molecular weight for
FccRIII [21,22]. In contrast, there was no band at the 40 kDa
position (data not shown), the molecular weight of FccRII, which
is also recognized by the anti-FccR antibody (mAb, clone 2.4G2)
used for Western blot analyses [23,24]. In accord with Figure 1A,B,
reverse direction immunoprecipitation using FccRIII antibody
followed TLR4 Western blots revealed bands at around 90 kDa,
consistent with the reported molecular weight of TLR4
(Figure 1C,D). However, under these conditions bands also
occurred after stimulation of phagocytes with LPS (Figure 1C,D),
which may suggest that FccRIII and TLR4 heterodimerize upon
LPS stimulation, although to a lesser extent as compared to IgGIC
treated cells. When PMNs and macrophages from FccRIII
2/2
mice were exposed to the same in vitro conditions (IgGIC, LPS,
LPS+IgGIC), the band for FccRIII failed to appear, confirming its
specificity (Figure 1E,F). In order to examine whether the
interaction between TLR4 and FccRIII was specific for these
two receptors or whether there also might be multimerization with
other TLRs or Fc receptors, lysates from Wt phagocytic cells
under various conditions (see above) were subjected to immuno-
precipitation with anti-TLR6 or anti-CD23 (anti-FceRII), followed
by Western blots for FccRIII or TLR4, respectively (Figure 1G–J).
In both combinations, specific bands for either FccRIII (after
immunoprecipitation with anti-TLR6; Figure 1G,H) or TLR4
(immunoprecipitation of cell lysates with anti-TLR6; Figure 1I,J)
failed to appear, whereas the strong bands in the lower panels
(loading controls) demonstrate that immunoprecipitation of the
samples worked properly. In addition, macrophages from Wt mice
were incubated with polymyxin-treated BSA IgGIC and PAP
IgGIC, followed by immunoprecipitation with anti-TLR4 and
Western blotting with anti-FccRIII. As shown in Figure 1K,
receptor heterodimerization occurred under these conditions as
well, confirming the results shown in Figure 1A,B.
In summary, these findings indicate that association of TLR4
and FccRIII occurs following activation of phagocytes with IgGIC
and/or LPS and that this receptor association is a specific
phenomenon for FccRIII and TLR4.
Attenuated In Vitro Cytokine Production by TLR4 Mutant
PMNs and Macrophages Following IgGIC or LPS Exposure
Elicited peritoneal neutrophils (PMNs) and macrophages were
obtained from Wt and TLR4 mut mice. The cells were incubated
in vitro with IgGIC or LPS. Subsequently, supernatant fluids were
collected and evaluated by ELISA for intereukin-6 (IL-6) and
tumour necrosis factor alpha (TNFa) levels (Figure 2). PMNs from
Wt mice showed significant release of IL-6 and TNFa after
exposure to either IgGIC or LPS. In the case of TLR4 mut PMNs,
cytokine responses to IgGIC or LPS were lost (Figure 2A–D).
Author Summary
The immune system is traditionally divided into innate and
adaptive entities. Pattern-recognition receptors (PRRs)
collectively recognize molecular structures of invading
microorganisms, followed by initiation of immune re-
sponses. PRRs comprise the toll-like receptor (TLR) family,
including TLR4, which is essential for responses to bacterial
lipopolysaccharide (LPS). As part of the adaptive immune
system, Fc receptors (FcRs) on immune cells recognize
antigen–antibody complexes and link antibody-mediated
immune responses to cellular effector functions. Here, we
describe cross-talk between the pathogen-recognition-
receptor toll-like receptor 4 (TLR4) and receptors for IgG
immune complexes (IgGIC), Fcc receptors (FccRs). We
found that TLR4 is involved in FccRIII (CD16) signaling and
that heterodimerization of TLR4 and FccRIII occurs in the
presence of IgGIC but not LPS. Consequently, dysfunc-
tional TLR4 signaling results in unresponsiveness of
immune cells in vitro to both LPS and IgGIC, resulting in
absence of acute lung injury after intratracheal adminis-
tration of LPS or intrapulmonary immune complex
deposition. In summary, we describe that TLR4 and FccRIII
pathways are structurally and functionally connected.
These findings provide new insights of the interplay
between innate and adaptive immunity, which closely
interact with each other at the receptor level and post
receptor signaling pathways.
Interaction of TLR4 and FccReceptorIII (CD16)
PLoS Pathogens | www.plospathogens.org 2 June 2009 | Volume 5 | Issue 6 | e1000464Figure 1. Association between TLR4 and FcRcIII. Peritoneal PMNs and macrophages (3610
6 cells/ml) from Wt mice and FcRc-subunit
2/2 mice
were incubated in vitro for 30 min with either IgG immune complexes (IgGIC; 100 mg/ml), LPS (20 ng/ml), or the combination. (A,B) Western blot
analysis (IB) for FccRIII of Wt PMN or macrophage lysates co-immunoprecipitated (IP) with anti-TLR4. (C,D) Reverse direction immunoprecipitation
using anti-FccRII/III IgG followed by Western blot analysis for TLR4. (E,F) Western blot analysis for FccRIII of PMNs or macrophages from FccRIII
2/2 co-
immunoprecipitated (IP) with anti-TLR4. (G,H) Samples were immunoprecipitated with anti-TLR6 IgG and probed for FccRIII. (I,J) Immunoprecipitation
with anti-CD23 followed by Western blots using anti-TLR4 IgG. (K) Western blots (IB) of cell lysates of Wt macrophages that were incubated for 30 min
with BSA IgG immune complexes (IgGIC; 100 mg/ml), polymyxin-treated BSA IgG immune complexes (p.-t. BSA IC; 100 mg/ml) or peroxidase/anti-
peroxidase IgGIC immune complexes (PAP IC, 100 mg/ml). IB for FccRIII of Wt macrophage lysates co-immunoprecipitated (IP) with anti-TLR4.
Corresponding loading controls are displayed in lower panels.
doi:10.1371/journal.ppat.1000464.g001
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protocol, similar results were found (Figure 2E,F). There was a
4-fold increase in IL-6 after exposure of Wt macrophages to LPS,
and a 3-fold increase in IL-6 after IgGIC exposure (Figure 2E).
Likewise, there was a robust release of TNFa by Wt macrophages
into supernatant fluids after stimulation with IgGIC or LPS. When
TLR4 mut macrophages were used under the same conditions, IL-
6 and TNFa responses to IgGIC or LPS were greatly abolished
(Figure 2E,F). Similar results were found when macrophages were
incubated with polymyxin-treated BSA IgGIC or PAP IgGIC
indicating that the results are reproducible and not based on LPS
contamination of the reagents (Figure 2E,F). Thus, the lack of a
functional TLR4 is associated with the in vitro inability of PMNs
and macrophages to respond to LPS or IgGIC.
In order to assess if the impaired response of TLR4 mut cells
observed in vitro might be due to a general impairment of the
inflammatory response, peritoneal PMNs and macrophages from
Wt and TLR4 mut mice were exposed to opsonized zymosan
particles as well as to Pam3Cys, which is a specific ligand for TLR2
[25,26,27] . As displayed in Figure S1, Wt cells showed a significant
increase of IL-6 (Figure S1A,C,E,G) and TNFa (Figure S1B,D,F,H)
releasewhen incubated in vitro with Pam3Cys or opsonized zymosan
particles. In contrast to the findings described above (incubation
with LPS or IgGIC), PMNs (Figure S1A–D) and macrophages
(Figure S1E–H) from TLR4 mut mice showed full responses for IL-
6 and TNFa when incubated with opsonized zymosan particles or
Pam3Cys. These data indicate that the ability to produce cytokines
in response to non-TLR4 agonists is intact in TLR4 mut cells and
that the impairment of the inflammatory response to LPS and
IgGIC is specific for the non-functional TLR4 protein.
In another set of experiments, cells from FccRIII-deficient mice
were tested for responsiveness to LPS. Peritoneal PMNs and
macrophages from Wt and FccRIII
2/2 were incubated with LPS
and opsonized zymosan (as a positive control) under the same
conditions described above and supernatant fluids were analyzed
for IL-6 and TNFa levels by ELISA. As shown in Figure 3,
Figure 2. In vitro cytokine responses of elicited peritoneal PMNs and macrophages to LPS and IgGIC. In vitro cytokine responses of
elicited peritoneal PMNs (A–D) and macrophages (E,F). Cells (3610
6 cells/ml) from either Wt or TLR4 mut mice were incubated for 4 hr with LPS
(20 ng/ml) or IgGIC; 100 mg/ml), respectively. In addition, macrophages were incubated with polymyxin-treated BSA IgG immune complexes (p.-t.
BSA IC, 100 mg/ml) or peroxidase/anti-peroxidase IgGIC immune complexes (PAP IC, 100 mg/ml). (A) IL-6 release from PMNs after LPS stimulation. (B)
TNFa levels after incubation of PMNs with LPS. (C) Concentration of IL-6 in supernatants when PMNs were exposed to IgGIC. (D) Production of TNFa
by PMNs and macrophages in the presence of IgGIC. Ctrl=control levels of non-stimulated cells. (E) Release of IL-6 by macrophages into supernatant
fluids after stimulation with LPS, IgGIC, p.-t. BSA IC, or PAP IC. (F) TNFa production by macrophages exposed to LPS, IgGIC, p.-t. BSA IC, or PAP IC. The
experiments were performed in triplicates for each condition (each bar) with n$3 donors of cells for each mouse strain, Wt or TLR4 mut. Differences
between controls and stimulated cells were—if not otherwise noted—statistically significant (p,0.05).
doi:10.1371/journal.ppat.1000464.g002
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+/+ and FccRIII
2/2 mice robustly
produced cytokines when incubated with LPS, opsonized zymosan
or IgGIC. There was no difference in cytokine secretion between
the FccRIII
+/+ and FccRIII
2/2 cells, except for LPS-induced
TNFa release by FccRIII
2/2 PMNs, which was lower as
compared to FccRIII
+/+ PMNs, but significantly elevated above
baseline levels. As expected, FccRIII
+/+ macrophages robustly
released IL-6 and TNFa into supernatant fluids when stimulated
with IgGIC, whereas macrophages from FccRIII
2/2 mice were
unresponsive to IgGIC (Figure 3C,D).
These results suggest that FccRIII-deficient phagocytes can
respond to LPS and that FccRIII is not required for direct TLR4
signaling, while FccRIII is essential for the mediation of IgGIC-
induced responses.
Figure 3. Responsiveness of FccRIII-deficient phagocytes to LPS. Peritoneal PMNs (A,B) and macrophages (C,D) from Wt and FccRIII
2/2 mice
were incubated to LPS (100 ng/ml) or Zymosan (300 mg/ml), or IgG immune complexes (IgGIC; 100 mg/ml; macrophages only), and supernatant fluids
were analyzed for IL-6 and TNFa levels. Ctrl=control levels of non-stimulated cells. For each condition, n$4. Differences between controls and
stimulated cells were—if not otherwise noted—statistically significant (p,0.05).
doi:10.1371/journal.ppat.1000464.g003
Interaction of TLR4 and FccReceptorIII (CD16)
PLoS Pathogens | www.plospathogens.org 5 June 2009 | Volume 5 | Issue 6 | e1000464Phosphorylation of FcR c-Subunit Requires the Integrity
of TLR4
After binding of LPS, TLR4 engages intracellular signaling
pathways via the adaptor molecules MyD88 and TRIF [27]. In
the case of FccR-immune-complex interaction, intracellular
pathways are activated by tyrosine phosphorylation of the FcRc-
subunit ITAM region [8,28]. This subunit is known to be the
common adaptor of FccRI, FccRIII and FceRI [29,30], the first
two being essential for development of IgGIC induced acute lung
injury [31]. In order to evaluate the mechanism behind the
impaired response of TLR4 mut cells to IgGIC, tyrosine
phosphorylation of the FcRc-subunit was investigated in vitro.
When peritoneal PMNs (Figure 4A) or macrophages (Figure 4B)
from Wt mice were exposed to IgGIC, rapid tyrosine phosphor-
ylation (PY) of the FcRc-subunit occurred over the first 30 min, as
indicated by robust bands in the Western blots. In striking
contrast, phosphorylation of the FcRc-subunit failed to occur
when TLR4 mut cells were used. Here, the intensity of the bands
was comparable to those in non-stimulated cells (Figure 4A,B).
When LPS was used as a stimulus (Figure 4C,D), slight
phosphorylation of the FcRc-subunit occurred in Wt cells (but
not in TLR4 mut cells), indicating that TLR4 has little ability to
activate the FcRc-subunit as an intracellular signaling event
(Figure 4C,D). Furthermore, the above mentioned results were
confirmed in macrophages by using polymyxin-treated BSA
IgGIC for stimulation under the same conditions in order to
exclude LPS contamination of the reagents (Figure 4E). Collec-
tively, these data suggest that the integrity of TLR4 seems to be
required for a proper function of FccR activation via phosphor-
ylation of the FcRc-subunit, further suggesting communication
between the TLR4 and FccR signaling pathways.
Acute Lung Injury in Wt, TLR4 Mutant, and TLR4
2/2 Mice
Using the LPS and IgGIC models of ALI, Wt, TLR4 mut,
TLR4
+/+ and TLR4
2/2 micewere evaluated for responses following
lung deposition of IgGIC or LPS. While FccRs play a key role in the
IgG immune complex (IgGIC) model of ALI [31,32], TLR4 is critical
for the development of lung injury in the LPS model [33,34,35]. As
indicated in Figure 5A, LPS-induced lung injury, as defined by the
permeability index (leak of plasma albumin into the extravascular
lung compartment), showed a 4-fold increase in Wt mice (compared
to controls, ctrl) and remained at the control level in LPS-challenged
T L R 4m u tm i c e .I nt h ec a s eo fI g G I C( F i g u r e5 B ) ,t h ep e r m e a b i l i t y
index rose 5-fold above control (basal) levels in Wt mice. However,
TLR4 mut mice unexpectedly showed no evidence of injury after
deposition of IgGIC (Figure 5B). TLR4
2/2 mice behaved similar to
TLR4 mut mice in terms of lung injury, with virtually no lung injury
in responseto deposition ofeither LPS or IgGIC (Figure 5A,B).When
Figure 4. Western blot analysis for tyrosine-phosphorylated (PY) FcRc-subunit of PMN or macrophage lysates after in vitro
incubation. (A,B) 3610
6 cells/ml from either Wt or TLR4 mut mice were incubated for 5, 15, and 30 min with IgG immune complexes (IgGIC; 100 mg/
ml). (C,D) The same protocol was used for stimulation with LPS (20 ng/ml). (E) Lysates from either Wt or TLR4 mut mice that were incubated with
polymyxin-treated BSA immune complexes (100 mg/ml) under the same conditions as described above. Corresponding loading controls are displayed
in the lower panels.
doi:10.1371/journal.ppat.1000464.g004
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LPS and IgGIC induced high levels of IL-6 in Wt mice and very low
levels in TLR4 mut mice(Figure 5C). Similar patterns werefound for
TNFa levels (Figure 5D).
Similarly, induction of ALI by intrapulmonary deposition of
polymyxin-treated BSA IgGIC in Wt and TLR4 mut mice
(Figure 5E) revealed no difference to the results displayed in
Figure 5B; when polymyxin-treated reagents were administered
for intrapulmonary IgGIC formation lung permeability rose 3.5
fold in Wt mice whereas mice TLR4 mut mice did not show a
significant increase. Thus, these findings support the conclusion
that lung injury induction by IgGICs is not linked to contamina-
tion of the reagents with endotoxin. In addition, reagents that were
used for the formation of IgGIC were administered separately in
vivo at the same concentration as they were used in combination
for intrapulmonary IgGIC deposition (Figure 5F). When BSA was
injected intravenously, followed by intratracheal PBS injection
lung permeability was not different from control mice. Similarly,
intratracheal injection of anti-BSA and subsequent intravenous
DPBS injection (containing a trace amount of I
125-labelled BSA)
did not result in increased lung permeability. In striking contrast,
the combination of anti-BSA (i.t.) and by BSA (i.v.) injection lead
to the development of acute lung injury, as also shown in Figure 5B
and 5E. These data indicate that the development of lung injury in
the IgG model is dependent on the in vivo formation of immune
complexes and may not be explained by putative LPS contam-
ination of the reagents since their separate, independent
administration failed to increase lung permeability. Finally, IgGIC
lung injury was induced in FcR c-subunit-deficient mice, which do
not express FccRI and FccRIII on the surface of PMNs and
macrophages [36]. In contrast to Wt mice (FcR c-subunit
+/+), FcR
c-subunit
2/2 mice did not develop acute lung injury after
intrapulmonary IgGIC deposition, as determined by lung
permeability (Figure 5G). These findings suggest that the IgGIC-
induced lung injury using anti-BSA and BSA is strictly dependent
on the FccR-mediated signalling, and not on LPS-induced
activation of TLR4. However, the caveat remains that there is
always a concern about LPS contamination in the context of
sensitive assays and in vivo responses. In particular, the possibility
that LPS was present at concentrations below the detection limit of
the available assays, which would not result in any in vivo (and in
vitro) responses alone, but would be responsible for putative
synergistic effects and an augmentation of IgGIC-induced
inflammatory responses cannot be entirely excluded.
Figure 5. Parameters of acute lung injury in Wt and TLR4 mut mice. (A) Lung injury (as measured by leak of
125I-BSA into lung) in Wt, TLR4
mut, TLR4
+/+, and TLR4
2/2 mice receiving LPS intratracheally. (B) Permeability indices in Wt, TLR4 mut, TLR4
+/+, and TLR4
2/2 mice after
intrapulmonary immune complex formation following administration of BSA (i.v.) and anti-BSA IgG (i.t.). (C) IL-6 levels in BAL fluids after IgG immune
complex (IgGIC)- or LPS-induced lung injury using Wt and TLR4 mut mice. (D) TNFa in BAL fluids from the same mice described in frame (C). For each
bar, n$5. (E) Lung injury induced by IgG immune complexes (IgGIC) in Wt and TLR4 mut mice after endotoxin removal by polymyxin. (F) Lung
permeability after intratracheal (i.t.) administration of anti-BSA IgG and intravenous (i.v.) injection of BSA, PBS i.t., and BSA i.v. or anti-BSA i.t. and PBS
i.v. (G) IgGIC-induced lung injury in FcRc-subunit
2/2 mice in comparison to Wt mice (FcRc-subunit
+/+). For each bar, n$5.
doi:10.1371/journal.ppat.1000464.g005
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TLR4 Mutant Mice
It is well established that engagement of FccRIII with IgGIC as
well as activation of the complement system with generation of
C5a and its interaction with C5aR play crucial roles in the
pathogenesis of IgGIC-induced ALI [31,37,38]. Therefore,
elicited peritoneal PMNs were evaluated by flow cytometry for
surface expression of FccRII/III and C5aR protein. As shown in
Figure 6A,F, the levels of each receptor on the surface of PMNs
were the same in Wt versus TLR4 mut cells. The original flow
cytometry data of FccRII/III expression on Wt and TLR4 mut
PMNs are displayed in Figure 6B,C. In addition, the total content
of FccRIII and FcRc-subunit in cell lysates from Wt and TLR4
mut PMN (Figure 6D) and macrophages (Figure 6E) were
analyzed by Western blotting. In accordance with the flow
cytometry results (Figure 6A,B), unstimulated phagocytes from
both mouse strains expressed the same levels of FccRII/III and
FcRc-subunit. The analysis for the house keeping protein GAPDH
(lower bands) indicates equal loading of the cell lysates. Thus, the
inability of TLR4 mut mice to respond to IgGIC or LPS is not
associated with reduced surface content of FccR protein on
PMNs, consistent with the findings that there is cross-talk between
FccR and TLR4 signaling pathways such that downstream
production of IL-6 and TNFa upon IgGIC stimulation requires
participation of both pathways. Collectively, these data indicate
that TLR4 is required for proper FccRIII functions.
Discussion
The mechanisms by which the recognition of pathogens leads to
host responses are inadequately understood. The modulation of
immune responses is inter alia mediated by cell surface receptors
that are associated with signaling molecules that contain ITAMs
(immunoreceptor tyrosine-based activation motifs), TREMs (trig-
gering receptors expressed on myeloid cells) and OSCARs (human
osteoclast-associated receptors) [1]. Intracellular signaling after
TLR4 activation is mediated through the adaptor proteins,
MyD88 and TRIF, whereas FccRI and FccRIII both contain
the FcRc-subunit, which is phosphorylated at tyrosine residues by
Src and Syk kinases upon FccR activation [28,30,39,40].
Interestingly, ligation of FcRc-subunit containing FcRs results in
inhibition of IL-12 production by monocytes in response to TLR
ligands [41]. The specificity of IL-12 downregulation appears to be
based on inhibition at the transcription level [41]. Moreover,
TLRs are considered to control activation of acquired immunity
[14], supporting the hypothesis for an instructive role of innate
immunity in adaptive immune responses [15].
Figure 6. Expression levels of FccRII/III, FcRc-subunit, and C5aR on phagocytes from Wt and TLR4 mut mice. (A) Summary of flow
cytometry analyses of FccRII/III expression on blood PMNs. (B,C) Original flow cytometry results for FccRII/III expression on the surface of PMNs from
Wt (B) or TLR4 mut (C) mice. (D,E) Analysis of the expression of FccRIII (upper bands) and FcRc-subunit (middle bands) in cell lysates [(D), PMNs; (E),
macrophages] from Wt or TLR4 mut mice by Western blotting. The lower bands represent the analysis for GAPDH as loading controls. (F) Surface
expression of C5aR protein on PMNs from Wt or TLR4 mut mice as assessed by flow cytometry. MFI, mean fluorescence intensity. Studies were done
in three separate and independent experiments, with each sample run in duplicates.
doi:10.1371/journal.ppat.1000464.g006
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associate, possibly by heterodimerization, following stimulation with
IgGIC in vitro (Figure 1). Binding of IgGICs to the extracellular
domain of FccRs causes clustering of these receptors, followed by
phosphorylation of tyrosine residues within the ITAM region, and
subsequent activation of intracellular signaling cascades [28,30,40].
TLR signaling is initiated by dimerization of TLRs, which can form
homo- or heterodimers [42]. Previously, it has been suggested that
TLR4 co-associates with FccRIII after activation of human
monocytes [43]. Based on our findings, it is possible that TLR4
and FccRIII multimerize into clusters following stimulation by LPS
or IgGIC,a mechanismknown as capping [44], which is required for
engagement of intracellular signaling pathways. TLR4 may represent
the central component for such signaling or ‘‘docking platforms’’ [45]
and interconnect intracellular signaling pathways via association to
adaptor proteins. As demonstrated in the present study, dysfunction
of TLR4results inimpaired signaling in FccRIII pathways (Figure 4).
The mutation that is responsible for the endotoxin tolerance of
C3H/HeJ mice has recently been demonstrated to cause
suppressed tyrosine phosphorylation by Src tyrosine kinases
(Lyn) in the toll-IL-1 resistance (TIR) domain of TLR4, resulting
in signaling-incompetence [45]. Altered or suppressed TLR4
tyrosine phosphorylation correlated with impaired MyD88
association and suppressed IRAK-1 activation [45]. In addition,
our data suggest that this mutation in the TLR gene not only
hinders phosphorylation of its own TIR domain but also blocks the
tyrosine phosphorylation of the ITAM-containing FcRc-subunit,
the consequence of which ultimately leads to impaired signaling
after engagement of FccRIII.
In the LPS model of acute lung injury, TLR4 mut or TLR4
2/2
mice were, as expected, highly protected from the development of
tissue damage in the LPS-induced model of acute lung injury
(Figure 5). It is well established that mice with mutation in the
TLR4 gene or genetic deficiency of TLR4 are non-responsive to
LPS [4], including LPS-mediated lung injury [33,34,35]. In the
present study, TLR4 mut and TLR4
2/2 mouse strains unexpect-
edly also showed greatly attenuated susceptibility to IgGIC-
induced lung injury (Figure 5). For this model, it is known that,
besides complement activation, FccRs are critical for initiation
and development of IgGIC alveolitis [31,32], particularly through
engagement and activation of ITAM-containing FccRs (FccRI
and FccRIII) [31]. In accordance, mice with targeted disruption of
the FcRc-subunit showed an impaired inflammatory response in
the reverse passive Arthus reaction [46]. In our study, TLR4 mut
mice not only were resistant to lung injury, but also failed to locally
release cytokines in vivo after intrapulmonary IgGIC deposition, as
indicated by baseline levels of IL-6 and TNFa in BAL fluids
(Figure 5). In companion experiments, in vitro exposure of TLR4
mut phagocytes to IgGIC resulted in complete suppression of
proinflammatory cytokines (TNFa, IL-6) in comparison to
phagocytes from Wt mice (Figure 2). Furthermore, TLR4 mut
cells showed impaired tyrosine phosphorylation of the FcRc-
subunit when exposed to IgGIC, in striking contrast to Wt cells
(Figure 4). The fact that TLR4 mut PMNs and macrophages
responded with cytokine release when incubated with opsonized
zymosan particles or with Pam3Cys (Figure 3) indicates that 1.) the
mutation in the TLR4 gene does not lead to a global impairment
of the cellular inflammatory/immune response and 2.) the
intracellular signaling pathways are intact since other TLRs (such
as TLR2 and TLR6), which share common pathways, could be
activated in vitro. On the other hand, phagocytes from FccRIII-
deficient mice are fully responsive to LPS (Figure 3), suggesting
that TLR4 signaling does not depend on the functional integrity of
FccRIII, whereas TLR4 is required for FccRIII signaling.
Especially in the field of immunology, there is an increasing
number of reports describing effects of receptor interactions.
Examples include a previous study suggesting cross-talk between
IFN-gamma and IFN-alpha receptors with signaling pathways [47].
In brief, signalling by IFN-gamma was shown to depend on the
IFN-alpha/beta receptor components. A more recent publication
describes that signalling triggered by NKG2D and DAP10 is
coupled to the interleukin 15 receptor signalling pathway,
suggesting that coupling of activating receptors to other receptor
systems may regulate cell type-specific signaling events [48]. In the
case of innate immunity, it has been proposed several times that
there is a link between TLR4 and the complement system,
especially to the C5a signalling pathway, which can negatively
regulate TLR4-induced responses [49,50]. Under physiological
conditions, receptor interactions and cross-talk between signalling
pathways might represent important regulatory mechanisms of the
immune system to provide distinct but fine-tuned responses. In the
case of TLR4 and FccRIII, cross-talk may provide an optimal and
rapid response against invading microorganisms by mediating an
interplay between adaptive and innate immunity. However, in
certain conditions, such as systemic inflammation (sepsis) or
autoimmune diseases that are characterized by a loss of inhibitory
action or uncontrolled activation of signalling pathways, a loss of
control over otherwise carefully orchestrated receptor interactions
can become instruments of harm.
Taken together, the present findings strongly suggest that (i)
there is a direct link between TLR4 and FccR pathways, (ii)
phosphorylation of tyrosine residues in the ITAM-containing
FcRc-subunit requires the presence and integrity of TLR4 during
cellular activation after binding of IgGICs to FccRs, and (iii)
presence of IgGICs results in an association between TLR4 and
FccRIII (CD16) on phagocytic cells. These data imply that innate
and adaptive immunity are closely connected at the receptor level
and post receptor signaling pathways, which might have
ramifications for a variety of inflammatory conditions, such as
IgGIC-mediated autoimmune diseases (rheumatoid arthritis or
glomerulonephritis), ischemia/perfusion injury, trauma or system-
ic inflammation (sepsis), etc.
Materials and Methods
Animals
Adult male (22–25 g) specific pathogen-free C3H/OuJ (Wt) and
C3H/HeJ (TLR4 mut) mice with a missense mutation in the
TLR4-gene were used in these studies [4]. In addition, lung injury
was employed in mice lacking the genes for TLR4 (TLR4
2/2;
C57BL/10ScCr) and the corresponding wild-type mice (TLR4
+/+;
C57BL/ScSn) [4]. In some in vitro experiments, cells from
FccRIII-deficient (FccRIII
2/2; B6.129P2-Fcgr3
tm1Sjv/J), FcR c-
subunit-deficient (FcRc-subunit
2/2; B6.129P2-Fcer1g
tm1RavN12)
and appropriate Wt mice (C57BL/6) were used [51].
Ethics Statement
All studies were performed in accordance with the University of
Michigan Committee on Use and Care of Animals.
In Vitro Incubation of Peritoneal PMNs and Macrophages
Mouse peritoneal leukocytes were harvested 5 h (PMNs) or 5 days
(macrophages) after intraperitoneal injection of thioglycolate into
untreated Wt and TLR4 mut mice by peritoneal lavage with PBS.
3610
6 cells / sample were incubated in HBSS for up to 4 h at 37uC
in the presence of LPS (20 ng/ml; serotype O111:B4; Sigma, St.
Louis, MO), BSA IgG immune complexes (IgGIC, 100 mg/ml; MP
Biomedicals), polymyxin-treated BSA IgG immune complexes (p.-t.
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complexes (PAP IC, 100 mg/ml; MP Biomedicals), opsonized
zymosan particles (300 mg/ml; Sigma) or Pam3Cys (1 mg/ml;
InvivoGen). After incubation, supernatant fluids were collected for
assessment of cytokines by ELISA and pellets were lysed with RIPA
buffer (Upstate) for immunoprecipitation analyses.
Immunoprecipitation and Western Blotting
After incubation of peritoneal PMNs or macrophages with
either IgG immune complexes (100 mg/ml; prepared as described
elsewhere [52] or LPS (20 ng/ml) for 5 to 30 min, supernatant
fluids were removed and pellets were lysed with 1X RIPA buffer
containing Vanedate and protease inhibitors (Roche Diagnostics).
Protein concentrations were determined in cell lysates using BCA
protein assay (Pierce). Equal protein amounts of supernatants were
then incubated overnight with preblocked protein A and G beads
(Santa Cruz) in the presence of anti-FcRc-subunit IgG (Upstate) or
anti-TLR4 IgG(Santa Cruz), respectively. Reverse direction
immunoprecipitation included anti-FccRIII IgG (Santa Cruz).
After centrifugation, pellets were resuspended in Laemmli
sample buffer (Biorad) followed by boiling of the samples. After
a final spin step, supernatant fluids were electrophoretically
separated under reducing conditions in SDS-PAGE and trans-
ferred onto PVDF membrane. The membrane was blocked in 5%
bovine milk in TBST and then probed for TLR4 or FccRIII using
polyclonal anti-TLR4 IgG (1 mg/ml, Santa Cruz) or monoclonal
anti-FccRII/III IgG (1 mg/ml; clone 2.4G2; BD Pharmingen).
Alternatively, membranes containing the samples co-immunopre-
cipitated with anti-FcRc-subunit IgG were incubated with anti-
phospho-tyrosine monoclonal antibody (1 mg/ml; clone 4G10,
Upstate). As secondary antibodies, HRP-conjugated donkey anti-
goat IgG (1:80,000; Jackson Immunoresearch), HRP-conjugated
goat anti-rat IgG (1:10,000; Amersham) HRP-conjugated donkey
anti-rabbit IgG (1:10,000; Amersham) and HRP-conjugated sheep
anti-mouse IgG (1:20,000; Amersham) were added and the blot
was developed using ECL-procedure (Amersham).
ELISA for Mouse IL-6, TNFa
For measurement of IL-6 and TNFa in BAL fluids and
supernatant fluids after in vitro incubation of mouse PMNs and
macrophages, commercially available ELISA-kits (‘‘Duo set’’, R&D
Systems) were used according to the manufacturer’s protocol.
Immune Complex Lung Injury
To induce IgGIC lung injury, tracheae of mice were surgically
exposed and 125 mg rabbit anti-BSA IgG (MP Biomedicals) was
administered using a 30 gauge needle (volume of 42 ml/mouse)
followed by intravenous injection of BSA (500 mg; Sigma). For
determinationof the permeability index as a quantitative marker for
vascular leakage,
125I-labelled bovine serum albumin (1 mCi
125I-
BSA/mouse) was injected intravenously. After the development of
acute lung injury, the pulmonary vasculature was flushed with
2.0 mlPBS.Theamountoflung radioactivitywas then measuredas
a ratio of radioactivity present in 100 ml blood recovered from the
inferior vena cava at the time of animal euthanasia and that in lung.
For bronchoalveolar lavage retrieval, lung injury was performed as
described above, but without the intravenous injection of
125I-BSA.
The airways were flushed with 0.8 ml ice cold PBS using a blunt 20
gauge needle and BAL fluids were recovered for further studies.
LPS Lung Injury
50 mg LPS from E.coli (serotype O111:B4; Sigma) were given
intratracheally (volume of 42 ml/mouse). When lung permeability
was measured, a trace amount of
125I-BSA was injected
intravenously, as described above. The permeability index was
determined and BAL fluids were collected as described for the
IgGIC model.
Detection of Possible LPS Contamination
Reagents other than LPS, such as DPBS, BSA, anti-BSA IgG that
were used for the in vivo and in vitro experiments were tested for LPS-
contamination. For quantification of LPS content, samples were
conducted in Limulus Amebocyte Lysate Kinetic-QCL assay
(Cambrex)according to the manufacturer’sprotocol and as described
elsewhere [53]. In addition, reagents used for immune complex
formation (DPBS, BSA, anti-BSA IgG) were subjected to endotoxin
removal (Pierce) prior to induction of lung injury or preparation of
immune complexes used stimulation of phagocytes in vitro.
Analysis of FccR and C5aR on PMNs
Flow cytometric analysis was conducted after whole blood
collection of untreated wild-type and TLR4 mut mice in a citrate-
containing syringe. Rabbit anti-mouse C5aR serum (1:10 dilution;
Lampire) was incubated with mousewholeblood. Non-specificrabbit
serum (Jackson Immunoresearch) was added to control samples in
equal amounts. For detection of FccR on PMNs, mouse whole blood
was either incubated with 1 mg monoclonal anti-FccRII/III IgG
(clone 2.4G2; BD Pharmingen) or with the appropriate isotype IgG
control (Jackson Immunoresearch). After washing, cells were
suspended in Phycoerythrin (PE)-labeled anti-rabbit IgG (Invitrogen)
diluted 1:200 in staining buffer and incubated at room temperature
for 45 min. Erythrocytes were lysed by addition of 16FACS lysing
solution (BD Pharmingen) for 10 min. After washing, the leukocytes
were resuspended in a 1%-paraformaldehyde fixing solution and
analyzed on a flow cytometer (BD Pharmingen).
Statistical Analysis
All values were expressed as mean6SEM. Data sets were
analyzed by one-way analysis of variance (ANOVA); differences in
mean values among experimental groups were then compared
using Tukey multiple comparison test. Results were considered
statistically significant when P,0.05.
Supporting Information
Figure S1 Cytokine response of PMNs and macrophages to
Zymosan and Pam3Cys. In vitro cytokine responses to non-TLR4
agonists of elicited peritoneal phagocytes from Wt or TLR4 mut
mice. PMNs (A–D) and macrophages (E–H) (3610
6 cells/ml) were
incubated (for 4 hr) with serum-opsonized zymosan particles
(300 mg/ml) or Pam3Cys (1 mg/ml). Ctrl=control levels of non-
stimulated cells. For each condition n$3. Differences between
controls and stimulated cells were found to be statistically
significant (p,0.05).
Found at: doi:10.1371/journal.ppat.1000464.s001 (0.50 MB EPS)
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